Shlomit Jessel
- Oncology
- Public Health, Environmental and Occupational Health
- Immunology
- Reproductive Medicine top 10%
- Molecular Biology
- Co-authors
- Harriet M. KlugerCarmela FelzRaoul OrvietoBenjamin FischRonit AbirAvi Ben‐HaroushSarah A. WeissLiliana E. Lucca
- Topics
- Cancer Immunotherapy and Biomarkers (7 papers)CAR-T cell therapy research (5 papers)Renal cell carcinoma treatment (2 papers)
- Partner nations
- United StatesIsraelGreece
In The Last Decade
Shlomit Jessel
12 papers receiving 205 citations
Peers
Comparison fields: 5 of 42
- Oncology 96
- Public Health, Environmental and Occupational Health 66
- Immunology 56
- Reproductive Medicine 52
- Molecular Biology 51
Countries citing papers authored by Shlomit Jessel
This map shows the geographic impact of Shlomit Jessel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shlomit Jessel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shlomit Jessel more than expected).
Fields of papers citing papers by Shlomit Jessel
This network shows the impact of papers produced by Shlomit Jessel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shlomit Jessel. The network helps show where Shlomit Jessel may publish in the future.
Co-authorship network of co-authors of Shlomit Jessel
This figure shows the co-authorship network connecting the top 25 collaborators of Shlomit Jessel. A scholar is included among the top collaborators of Shlomit Jessel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shlomit Jessel. Shlomit Jessel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 5 | |
| 3 | 5 | |
| 4 | 47 | |
| 5 | 5 | |
| 6 | 4 | |
| 7 | 9 | |
| 8 | Mycophenolate as Primary Treatment for Immune Checkpoint Inhibitor Induced Acute Kidney Injury in a Patient with Concurrent Immunotherapy-Associated Diabetes: A Case Report. | 10 |
| 9 | 1 | |
| 10 | 45 | |
| 11 | 7 | |
| 12 | 67 |
About Shlomit Jessel
Shlomit Jessel is a scholar working on Transplantation, Oncology and Immunology, having authored 12 papers that have together received 210 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (5 papers) and Renal cell carcinoma treatment (2 papers). The work is most often cited by research in Reproductive Medicine (52 citations), Oncology (96 citations) and Immunology (56 citations). Shlomit Jessel has collaborated with scholars based in United States, Israel and Greece. Frequent co-authors include Harriet M. Kluger, Carmela Felz, Raoul Orvieto, Benjamin Fisch, Ronit Abir, Avi Ben‐Haroush, Sarah A. Weiss, Liliana E. Lucca, Lin Zhang and Michael E. Hurwitz. Their work appears in journals such as The Journal of Experimental Medicine, Fertility and Sterility and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.